Tariffs Are Bad Medicine
Tweet Here’s a letter to the Wall Street Journal. Editor: Shyam Sankar and Julia Dimon offer some sound advice to increase U.S. production of pharmaceutical products, such as renewing (as they put it) “the bonus depreciation for capital equipment included in the 2017 Tax Cuts and Jobs Act and extend it to commercial structures such as factories” (“The Bitter Pill of Reliance on China,” April 18). But their case for protective tariffs on Chinese-made pharmaceutical products is weak. […]